NEJM Group’s Post

In Session 4 of the 1st GetReal Institute Annual Conference the panelists discussed the topic ‘How do US Stakeholders use RWE for a better understanding of value?’ Mark McClellan (Duke-Margolis Center for Health Policy, US) led the session and was joined by Donna Rivera (FDA, US), virtually from the US, Irene Nunes (Flatiron Health, US) and Sengwee Darren Toh (Harvard Medical School & Harvard Pilgrim Health Care, US). Read the deep dive into this fascinating session at The Evidence Base® #realworlddata #realworldevidence #darwin #harper

🙏We would like to give a big shout-out to our dedicated jury members who went above and beyond in reviewing the outstanding nomination messages and carefully assessing the information provided for each initiative. The jury focused on key aspects such as: ✅level of engagement ✅PFMD quality criteria ✅the impact achieved and/or expected. We understand that #patientengagement (PE) initiatives have long-term effects, and it was crucial to evaluate their potential for lasting impact. 👏Thank you, Omar A. Escontrías, DrPH, MPH (National Health Council), Neil Bertelsen (HTAi Patient & Citizen Involvement in HTA Interest Group), Derick Mitchell (Irish Platform for Patient Organisations, Science, and Industry), Katherine Capperella, Paula Wray (University of Oxford), Leanne West (ICAN), Lode Dewulf, Zorana Maravic (Digestive Cancers Europe) for your invaluable contributions in recognizing and promoting impactful PE initiatives. Together, we are driving positive #lastingchange in healthcare! 💪 #ChangeAgents #SparkingSynapses

🙏We would like to give a big shout-out to our dedicated jury members who went above and beyond in reviewing the outstanding nomination messages and carefully assessing the information provided for each initiative. The jury focused on key aspects such as: ✅level of engagement ✅PFMD quality criteria ✅the impact achieved and/or expected. We understand that #patientengagement (PE) initiatives have long-term effects, and it was crucial to evaluate their potential for lasting impact. 👏Thank you, Omar A. Escontrías, DrPH, MPH (National Health Council), Neil Bertelsen (HTAi Patient & Citizen Involvement in HTA Interest Group), Derick Mitchell (Irish Platform for Patient Organisations, Science, and Industry), Katherine Capperella, Paula Wray (University of Oxford), Leanne West (ICAN), Lode Dewulf, Zorana Maravic (Digestive Cancers Europe) for your invaluable contributions in recognizing and promoting impactful PE initiatives. Together, we are driving positive #lastingchange in healthcare! 💪 #ChangeAgents #SparkingSynapses

Microvascular system in the heart

We are pleased to introduce the 2nd newsletter of the AFFIRMO project, a comprehensive initiative aimed at enhancing the clinical pathway for older patients managing both multimorbidity and #AtrialFibrillation (AF). 👥 In the ever-evolving landscape of healthcare, where the challenges posed by multiple chronic conditions are significant, AFFIRMO stands out by adopting a patient-centred approach. We prioritize individual needs and social contexts to ensure a holistic approach to care. 💡 As healthcare strategies adapt to meet the unique requirements of older individuals coping with multimorbidity and AF, #AFFIRMO reflects the consortium's unwavering commitment to delivering care beyond traditional models. We recognize the intricate health concerns our patients face and place a strong emphasis on inclusivity and empathy. 🤝 AFFIRMO actively involves patients in decision-making processes, fostering a collaborative environment where their voices shape the trajectory of their care. We believe that by working together, we can create a #healthcare experience that is not only compassionate but also tailored to the unique needs of each individual. Explore the innovative aspects of AFFIRMO with us, as we navigate the complexities of multimorbidity and AF, aiming to create a more compassionate and tailored healthcare experience. Join our efforts in ushering in a new era of patient-centric care, where the emphasis lies on the journey towards health, as much as the destination. 🔗 Check out our latest newsletter to stay updated on the work of the AFFIRMO project: https://lnkd.in/e_Cdt8DS Project Consortium Aalborg University  |  University of Liverpool  |  Ghent University  |  Karolinska Institutet  |  Consiglio Nazionale delle Ricerche  |  Università degli Studi di Padova  |  Carol Davila University of Medicine and Pharmacy  |  Moverim Consulting  |  Ontonix  |  Arrhythmia Alliance  |  University of Belgrade, School of Medicine  |  Istituto Superiore di Sanità  |  Advice Pharma Group S.R.L.  | Università Cattolica del Sacro Cuore  |  Fondazione per il Tuo cuore  |  The European Institute for Innovation Through Health Data  |  The University of Manchester  |  Universidad de Murcia  | MEDITCINSKY UNIVERSITET 

Enhancing integrated behavioural healthcare with digital therapeutics! Lots of research has been completed and is currently being conducted, increasing awareness and scientific acceptance. #digitaltherapeutics #vr #virtualreality #web3 #AI #360video #research #healthcare #metaverse

By listening to #MASH / #MASLD patient perspectives, we understand what tools and strategies work best to engage with patients from screening through study completion and beyond. ProSciento has developed approaches for improved patient access and engagement. Learn more and view our recent #MASH / #MASLD patient data poster: https://bit.ly/45Rdq7d #NationalPatientRecognitionWeek #ClinicalResearch #PatientsMatter #MetabolicContinuum